Pisano Wayne 4

What Happened

• Wayne Pisano, a director of Oncolytics Biotech Inc. (ONCY), purchased 30,000 common shares in open-market transactions on February 12, 2026. The filing reports a weighted average purchase price of $0.84 per share, for a total reported value of $25,338. This was a purchase (acquisition) rather than a sale.

Key Details

• Transaction date: 2026-02-12 (reported on Form 4 filed 2026-02-13). Transaction code: P (purchase).
• Price: weighted average $0.84 per share; purchases occurred in multiple trades at prices ranging $0.83–$0.85 (per filing footnote).
• Total reported value: $25,338.
• Shares owned after transaction: not specified in the provided filing summary.
• Footnote: The reported price is a weighted average; the filer will provide a breakdown of the number of shares bought at each separate price on request (see footnote F1).
• Timeliness: Filed the next day (appears timely); no late-filing indication in the provided data.
• No 10b5-1 plan, option exercise, gift, or tax-withholding notation was disclosed in the provided details.

Context

• Director purchases are often watched by investors as a sign of insider buying but do not by themselves prove company prospects. This purchase is modest in dollar terms (~$25k) and was made on the open market.